Type 2 Diabetes, Industry, Pharmaceutical - Market Trend, 2016 Demand, Analysis, Growth, Research 2016-17

"PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2025". The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect.

Description-

Summary

The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2015 and 2025, almost doubling over this period. The main drivers of growth will be the dramatic increase in disease prevalence and physicians efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded drugs. We anticipate that the type 2 diabetes market will experience a shift in the classes of drugs that are preferred by physicians. Rapid uptake of drugs from the glucagon-like peptide-1 receptor agonist (GLP-1RA) class and sodium-glucose co-transporter-2 inhibitor (SGLT-2I) class will occur; while dipeptidyl peptidase-4 inhibitors (DPP-4Is) will continue to grow, but at a much slower rate than previous years. GLP-1RAs and SGLT-2Is will experience the fastest growth of all classes at a CAGR of 12.2% and 13.0% respectively.

To Free Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=816331


Highlights

Key Questions Answered

- Although the T2D market has numerous well-established therapies, it is marked by the presence of a number of unmet needs in current treatments. What are the main unmet needs in this market? Will the drugs under development fulfil the unmet needs of the T2D market?
- The late-stage T2D pipeline is heavily populated with me-too drugs from the classes of GLP-1RAs, DPP-4Is, and SGLT-2Is. Despite this, an oral GLP-1RA formulation and an osmotic pump which delivers subcutaneous exenatide for one year at a time are expected to be game changers in the GLP-1RA class. Both are in Phase III clinical trials and are expected to increase compliance among T2D patients. Will the late-stage drugs make a significant impact on the T2D market? Which of these drugs will have the highest peak sales at the highest CAGR, and why?
- The diagnosed prevalence of T2D in the world skyrocketed in the past 10 years and will continue increasing at the fast pace. How will epidemiological changes impact the growth of the future market?

Key Findings

- The main driver of the enormous expansion of the T2D market will be the dramatic increase in disease prevalence, which is attributable to increased life expectancy and an increasingly sedentary and stressful lifestyle.

To Enquire Regarding This Report @ http://www.researchmoz.us/enquiry.php?type=E&repid=816331

- The second largest driver will be the physicians efforts to delay disease progression through the use of combination therapies and novel branded drugs.
- With the recent therapeutic guidelines putting emphasis on a patient-tailored approach in treating type 2 diabetes, pharmaceutical companies will achieve considerable success with their me-too drugs.
- In the future, companies will have to shift their focus towards competitive pricing, niche drugs aimed at smaller patient groups, and drugs that increase patient compliance (through more convenient administration).
- To date, no drug has demonstrated sustainable efficacy in the treatment of T2D. This unmet need presents a large opportunity for investment by drug developers.

Scope

- Overview of T2D, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized T2D therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2015 and forecast for ten years to 2025.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the T2D therapeutics market.
- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
- Analysis of the current and future market competition in the global T2D therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

For More Information Kindly Contact:

ResearchMoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States
866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,

Email to: sales@researchmoz.us, 
Location: United States

Comments

Post a Comment

Popular posts from this blog

Global Automated Fingerprint Identification System Market 2016-2020

Description- About Automated Fingerprint Identification System Fingerprint biometric technology is used to identify individuals using their fingerprints, which are scanned and matched against a database. The matching is executed on the basis of features, such as the arches, whorls, and loops, of the fingerprints. Pattern-based algorithms are used to match a person's fingerprints against databases to provide access to secure premises. In the early 2000s, with advances in technology, an advanced fingerprint system known as AFIS was introduced. AFIS can electronically capture data and analyze and identify a fingerprint pattern among millions of patterns. To Browse a Report Detail with TOC @ http://www.researchmoz.us/global-automated-fingerprint-identification-system-market-2016-2020-report.html Automated fingerprint identification involves automatic matching of one or more unknown fingerprints against an existing database of fingerprints. AFIS is mainly used b
Read more

Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019

Description - E-Prescribing : North America Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. E-Prescribing system has replaced the phone, paper and fax based method of prescription. The system improves patient safety by reducing prescribing errors due to various reasons, such as illegible handwriting and ambiguous abbreviations. It also reduces healthcare costs over the paper based prescription systems. It permits the physician and other healthcare professionals to regenerate a new prescription, when any prescription error occurs during pharmacy operation. To Browse a Report Detail with TOC @ http://www.researchmoz.us/global-market-study-on-e-prescribing-north-america-to-witness-highest-growth-by-2019-report.html The global E-Prescribing market is categorized based on various product type, components, delivery mode, usage
Read more

Global Handling and Lifting Equipment Industrial Trend and Market Demand 2016-2020

"Global Handling and Lifting Equipment Market 2016-2020" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- About Handling and Lifting Equipment Handling equipment is used in the transportation and storage of materials and assemblies. Material handling activities start from the unloading of goods to the transfer of these goods into storage, assembly, packaging, and finally loading for transportation. Handling equipment must be designed based on the various stages of production. Lifting activities consider factors such as lift radius, machine capacity at a given range, wind speed, and ground conditions. Lifting equipment has developed in terms of carrying capacity. Advanced equipment can perform complicated tasks with relative ease of movement, especially when compared to the traditional handling and lifting equipment. Get Sample Report With TOC @ http://www.researchmoz.us/en
Read more